Turkish Journal of Medical Sciences
Volume 46

Number 4

Article 15

1-1-2016

Kinesiotaping as an alternative treatment method for carpal
tunnel syndrome
DUYGU GELER KÜLCÜ
CANAN BURSALI
İLKNUR AKTAŞ
SELİN BOZKURT ALP
FEYZA ÜNLÜ ÖZKAN

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
KÜLCÜ, DUYGU GELER; BURSALI, CANAN; AKTAŞ, İLKNUR; ALP, SELİN BOZKURT; ÖZKAN, FEYZA ÜNLÜ;
and AKPINAR, PINAR (2016) "Kinesiotaping as an alternative treatment method for carpal tunnel
syndrome," Turkish Journal of Medical Sciences: Vol. 46: No. 4, Article 15. https://doi.org/10.3906/
sag-1503-4
Available at: https://journals.tubitak.gov.tr/medical/vol46/iss4/15

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Kinesiotaping as an alternative treatment method for carpal tunnel syndrome
Authors
DUYGU GELER KÜLCÜ, CANAN BURSALI, İLKNUR AKTAŞ, SELİN BOZKURT ALP, FEYZA ÜNLÜ ÖZKAN, and
PINAR AKPINAR

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol46/iss4/15

Turkish Journal of Medical Sciences

Turk J Med Sci
(2016) 46: 1042-1049
© TÜBİTAK
doi:10.3906/sag-1503-4

http://journals.tubitak.gov.tr/medical/

Research Article

Kinesiotaping as an alternative treatment method for carpal tunnel syndrome
1,

2

2

2

2

2

Duygu GELER KÜLCÜ *, Canan BURSALI , İlknur AKTAŞ , Selin BOZKURT ALP , Feyza ÜNLÜ ÖZKAN , Pınar AKPINAR
1
Department of Physical Medicine and Rehabilitation, Haydarpaşa Numune Education and Research Hospital, İstanbul, Turkey
2
Department of Physical Medicine and Rehabilitation, Fatih Sultan Mehmet Education and Research Hospital, İstanbul, Turkey
Received: 03.03.2015

Accepted/Published Online: 04.10.2015

Final Version: 23.06.2016

Background/aim: Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy. Conservative treatment choices are not
always satisfactory. The aim of this study was to investigate the effect of kinesiotaping (KT) on pain level, grip strength, and functional
status compared with that of placebo KT and orthotic device (OD) in patients with CTS.
Materials and methods: In this randomized, placebo-controlled study, participants were allocated into one of three groups: an
experimental KT group (Group 1), a placebo KT group (Group 2), and an OD group (Group 3). Visual analogue scale (VAS) and
Douleur Neuropathique 4 (DN4) scores, dynamometric grip strength measures, and the Boston CTS questionnaire (BQ) were the
outcome measures.
Results: All groups significantly improved in terms of VAS scores (P < 0.05), DN4 scores (P < 0.05), and BQ scores (P < 0.05). Grip
strength improved in Group 3 (P = 0.001). There was a significant difference among the groups with respect to BQ scores (P < 0.05).
Conclusion: KT application for the treatment of CTS should be an alternative treatment choice.
Key words: Kinesiotaping, carpal tunnel syndrome, pain, disability

1. Introduction
Carpal tunnel syndrome (CTS) is the most common
entrapment neuropathy and is caused by compression of
the median nerve at the wrist (1). The etiology of CTS
can result from prolonged static postures and repeated
wrist activities (2,3). The diagnosis of CTS is based on
symptoms, provocative tests, and nerve conduction studies
(NCSs). Various treatment approaches, individually or in
combination, have been recommended in the literature
for the conservative treatment of mild/moderate CTS,
including wrist orthotic devices (ODs), steroid injections
and nonsteroidal antiinflammatory drugs, vitamin
B12 supplementation, physical therapy agents, activity
modification, and tendon/nerve gliding exercises (4,5).
In recent years, kinesiotaping (KT) has become
increasingly popular for various musculoskeletal
conditions such as shoulder pain (6), patellofemoral pain
syndrome
(7), subacromial impingement syndrome (8), plantar
fasciitis (9), and spasticity (10).
However, there are not enough studies to show efficacy
in these conditions. It provides dynamic support and
protection to the injured/overused muscle, while allowing
* Correspondence: d_geler@yahoo.com.tr
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a functional and safe range of motion by either inhibition
or facilitation, according to the underlying pathology.
In addition to those concepts, Kase et al. (21) defined
several corrective techniques (neural, mechanical, fascia,
space, ligament/tendon, functional, circulatory/lymphatic
corrections) for several diagnoses.
In clinical practice, wrist ODs placed in a neutral
position are the first step of treatment. Local corticosteroid
injections and physical therapy modalities are also
preferred. However, physical therapy involves time
commitment of physiotherapists and patients. Local
injections may not be preferred by the patient because
they are invasive and not an exact solution for CTS. It has
been hypothesized that KT application, through neural
technique and space correction, and recommended by
Kase et al. (21) for CTS, should be an alternative treatment
method. The aim of the present study was to analyze the
effect of KT on pain, functional status, and grip strength
in patients with mild to moderate CTS by comparing
placebo KT and a well-known treatment method, a neutral
positioned wrist OD. To the best of our knowledge, this
is the first study to evaluate the efficacy of KT in patients
with CTS.
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2. Materials and methods

2.4. Outcome measures

2.1. Study design and participants
This was a prospective, randomized placebo-controlled
trial. Patients with symptoms of CTS including nocturnal
paresthesia, pain in the median nerve distribution during
activity, or numbness in the median nerve distribution
were examined. Patients with clinically suspected CTS
were referred to the electromyography laboratory of the
hospital. Mild and moderate CTS patients, according
to NCSs, were asked to participate in the study. Mild
CTS is defined as abnormal median nerve peak sensory
conduction velocity (<42 m/s) and normal median nerve
motor latency (<4 ms). Moderate CTS is defined as NCS
abnormalities for median nerve peak sensory conduction
velocity (<42 m/s) and abnormal median nerve motor
distal latency (>4 ms) (11).
Patients older than 18 years who had symptoms
for less than 1 year were included in the study. Patients
were excluded if there were any secondary entrapment
neuropathy (e.g., diabetes, inflammatory arthritis,
hypothyroidism, previous wrist trauma), pregnancy,
skin infection on the forearm, cervical radiculopathy,
polyneuropathy, previous history of carpal tunnel
decompression surgery, and corticosteroid injection into
the carpal tunnel.
The local Ethics Committee approved the study, and all
subjects gave written informed consent.

2.4.1. Pain level
The visual analogue scale (VAS) pain score is between 0
(no pain) and 10 (worst possible pain).
The DN4 questionnaire (12) consists of ten items. The
first seven items are related to pain characteristics and
sensations, and the remaining three items are related to the
examination. For each item, a score of “1” is given if the
answer is “yes”, and a score of “0” is given if it is “no”. The
patient is defined to have neuropathic pain if the sum of all
ten items is calculated to be 4 or greater. A Turkish version
of DN4 was validated by Unal-Cevik et al. (13).

2.2. Patient allocation
Forty-five patients (65 wrists) were included in the study.
Twenty patients had bilateral CTS. Occupation, age,
sex, dominant hand, and affected side were recorded as
demographic properties. Patients were randomly assigned
to one of the three groups using a secure system of opaque
closed envelopes numbered 1–3. Wrists of the patients with
bilateral CTS were allocated to the same group according to
the envelope number that the patient chose. The first group
received KT, the second group received sham KT, and the
third group received an OD, performed by a researcher not
involved in the study. Thirteen patients (22 wrists) from
Group 1, 13 patients (22 wrists) from Group 2, and 14
patients (21 wrists) from Group 3 completed the study. A
flow diagram of the patients is presented in Figure 1.
2.3. Assessments
All patients were examined by the Phalen test and Tinel
test. A manual muscle strength test and a sensorial
examination were performed. Outcome measures are
listed below. Patients with bilateral symptoms were
asked to complete two questionnaires, one for each hand
separately. Assessments were done before (T0) and after
the treatments (T1).

2.4.2. Functional status
The Boston questionnaire (BQ) (14) is self-administered
and assesses the severity of symptoms and functional status
in patients with CTS. The symptom severity scale (SSS)
assesses the symptoms with respect to severity, frequency,
time, and type. The scale consists of 11 questions with
multiple-choice responses, scored from 1 point (mildest) to
5 points (most severe). The overall symptom severity score
is calculated as the mean of the scores for the 11 individual
items. The functional status scale (FSS) assesses the effect
of CTS on daily living. The scale consists of eight questions
with multiple-choice responses, scored from 1 point (no
difficulty with the activity) to 5 points (cannot perform the
activity at all). The overall score for functional status was
calculated as the mean of all eight individual terms. Thus,
a higher symptom severity or FSS score indicates worse
symptoms or dysfunction; a Turkish version of the BQ was
validated by Sezgin et al. (15).
2.4.3. Grip strength
Assessment of grip strength was evaluated with a Riester
Dynatest hand dynamometer. Patients performed three
consecutive tests while sitting with their shoulder abducted
and neutrally rotated, elbow flexed at 90°, and forearm and
wrist in a neutral position. The mean score of the three
measurements was used in the statistical analysis.
2.5. Treatments
2.5.1. Group 1
Tape with a width of 5 cm and a thickness of 0.5 mm was
used. Kinesio Tex I Strip was measured from elbow to
fingertips and cut. It was folded approximately two blocks
from the end and cut into two triangles on the fold. The
third and fourth fingers were slipped through holes and
Kinesio Tex was applied on the dorsum of the hand with no
tension. The position of elbow extension, wrist extension,
and radial deviation was provided, and Kinesio Tex was
applied from hand to medial epicondyle with 15%–25%
tension and ended at medial epicondyle with no tension.
The second Kinesio Tex I Strip was measured for wrist size
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Figure 1. Flow diagram of the patients.

and cut. It was applied to the carpal tunnel region with
25%–35% tension (Figure 2a). This technique is a space
correction and neural technique described by the Kase et
al. (21). Applied tensions to KT were performed according
to the visible pores on KT. Subjects were taped by a doctor
certified to apply KT.
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2.5.2. Group 2
Tape with a width of 5 cm and a thickness of 0.5 mm
was used. Kinesio Tex I Strip was applied without having
the proper position and with no tension (in a manner
inconsistent with the technique, Figure 2b).

GELER KÜLCÜ et al. / Turk J Med Sci

Figure 2. a) Kinesiotape application; b) Placebo kinesiotape application.

Kinesiotape was applied to both groups at the
beginning of the week, to stay on for 5 days, with a 2-day
rest, for a total of four times.
2.5.3. Group 3
In the OD group, patients applied custom-made volar
thermoplastic wrist ODs in the neutral position. The
patients were encouraged to use the ODs night and day,
whenever possible, for 4 weeks. The rationale for the OD
is supported by anatomic and clinical studies. Anatomic
studies demonstrate that the pressure in the carpal tunnel
is at its lowest when the wrist is placed in a neutral
position and is at its highest when the wrist moves into
flexion and extension (16,17). The investigator applying
the treatments (CB) was different from the investigator
evaluating the outcome measures (SB); the latter was blind
to which series of treatments (experimental KT, placebo
KT, or OD) each patient was about to receive or had just
received. The patients in Group 1 and Group 2 were blind
to the treatments. All three groups received home exercise
programs during the 4 weeks, consisting of tendon-gliding
exercises. To follow up and to improve patient compliance,
each patient was asked to document what they did in a
supplied diary. This diary contains how many times they
did each exercise in a day. The diaries were checked every
visit. Patients who did not do the exercises regularly were
excluded from the study.

2.6. Sample size
In the initial study, a pilot study was conducted on 10
wrists from all three groups. In order to determine the
sample size, power analysis was performed using the G *
Power (v3.1.7) program. Seventeen wrists per group would
provide 80% statistical power and a 5% significance level
(effect size d = 1.0 to detect a 3 point difference in the VAS
scores among groups). To compensate for the dropouts, we
recruited 20 wrists per group.
2.7. Statistical analysis
The Number Cruncher Statistical System 2007 and Power
Analysis and Sample Size 2008 programs were used.
Descriptive statistics were given as means ± standard
deviation and numbers. Parameter values before treatment
(T0) and after treatment (T1) were compared using the
Wilcoxon signed-ranks test. Kruskal–Wallis test with
Bonferroni correction was used to compare the differences
among the groups. The significance level was set at P <
0.05.
3. Results
The mean age of the patients was 50.1 ± 85 (20–65) years;
95% of the patients were female and 5% were male. The
demographic properties of the groups are presented in
Table 1. There were no significant differences in terms of
demographic properties among the groups.
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Table 1. Demographic features of the groups.
Group 1 (KT a)
(n = 20)

Group 2 (placebo KT)
(n = 20)

Group 3 (orthotic device)
(n = 20)

P

Age (year) mean, Min–max

49.8 ± 11.5 (20–62)

48.95 ± 6.0 (40–60)

51.3 ± 8.3 (40–65)

0.493

Sex (Female/male) (n)

12/1

13/0

13/1

0.355

Employment
status

3 childminders (23%)
9 housewives (69%)
1 technician (8%)

2 retired (15%)
9 housewives (70%)
2 officials (15%)

3 retired (10%)
9 housewives (80%)
2 butchers (10%)

0.926

Dominant hand

Right 13 (100%)

Right 13 (100%)

Right 13 (92%)
Left 1 (8%)

0.126

Affected side

Right 13 (59%)
Left 9 (41%)

Right 12 (54%)
Left 10 (46%)

Right 12 (50%)
Left 12 (50%)

0.768

CTS b severity according to
electrophysiological studies

12 mild (54%)
10 moderate (46%)

8 mild (36%)
14 moderate (64%)

11 mild (45%)
13 moderate (55%)

0.710

KT a: Kinesiotaping; CTS b: Carpal tunnel syndrome.

3.1. Pain
VAS scores decreased in Group 1 (P = 0.001), Group 2 (P
= 0.009), and Group 3 (P = 0.030). There was no difference
among the groups regarding VAS scores after treatment (P
= 0.269).
DN4 scores significantly decreased in Group 1 (P =
0.005), Group 2 (P < 0.0001), and Group 3 (P = 0.024).
There was no difference among groups regarding DN4
scores after treatment (P = 0.842).
3.2. Grip strength
Grip strength improved in Group 3 (P = 0.001), but not in
Group 1 (P = 0.078) and Group 2 (P = 0.121). There was
no significant difference among the groups regarding grip
strength after treatment (P = 0.503). The results for pain
assessment and grip strength are shown in Table 2.
3.3. Functional status
3.3.1. Symptom severity subscale scores
The SSS scores improved in all three groups (P < 0.0001,
P < 0.0001, and P = 0.036, respectively). There was a
significant difference among the groups with respect to
SSS scores (P = 0.024); it was between Group 1 and Group
3, in favor of Group 1 (P = 0.009).
3.3.2. Functional status subscale scores
The FSS scores improved in Group 1 (P = 0.001), but did
not improve in Group 2 (P = 0.077) or Group 3 (P = 0.090).
There was a significant difference among the groups with
respect to FSS scores (P = 0.017). The only significant
difference was between Group 1 and Group 3 in favor of
Group 1 (P = 0.006).
3.3.3. Boston CTS questionnaire total scores
All three groups improved in terms of BQ scores (P <
0.0001, P = 0.011, and P = 0.038, respectively). There was a
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significant difference among the groups with respect to BQ
scores. The only significant difference was between Group
1 and Group 3, which was in favor of Group 1 (P = 0.008).
The results are shown in Table 3.
4. Discussion
In the present study, the treatment of patients with CTS
with KT, placebo KT, and splinting for 4 weeks provided
pain relief and decreases in symptom severity. However,
improvement in grip strength was observed only by
splinting, and improvement in functional status was
observed only by KT.
There are various studies that have investigated the
effect of KT by comparing placebo application on pain
relief in several musculoskeletal conditions such as
shoulder diseases and patellofemoral pain syndrome
(7–9). Similar to the results of the present study, Shakeri
et al. (9) found that both experimental KT and placebo
KT groups improved in terms of pain level and disability.
Contrary to these results, Aytara et al. (8) and Thelen et al.
(7) did not find any improvement in terms of pain level
in either experimental KT or placebo KT groups. They
concluded that this result is due to the low level of pain
intensity at baseline.
The aim of applying an OD to one of the groups was to
increase carpal tunnel volume and to decrease the pressure
on the median nerve (16). The KT pulls up the skin and
provides a space under the skin, directing connective
tissue to the expected area (18,19). On the other hand, KT
application can control the pulling force to a certain tendon
or ligament to avoid further injury, so that tissue repair
can be facilitated (9,20). In the present study, the direction
of the force applied was parallel to the direction of the
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Table 2. Pain and grip strength assessment of the groups.
Group 1 (KT c )
Mean ± sd (min–max)
(n = 20)

Group 2 (placebo KT)
Mean ± sd (min–max)
(n = 20)

Group 3 (orthotic device)
Mean ± sd (min–max)
(n = 20)

DN4 a - 1

5.5 ± 2.3 (1–9)

4.6 ± 2.6 (0–9)

4.5 ± 1.6 (1–8)

DN4 - 2

3.7 ± 2.3 (0–8)

3.0 ± 2.4 (0–9)

3.7 ± 2.0 (0–7)

P*

0.005

0.003

0.024

VAS b - 1

6.6 ± 2.1 (0–10)

5.8 ± 3.2 (0–10)

6.1 ± 2.9 (0–10)

VAS - 2

4.1 ± 2.7 (0–8)

3.9 ± 2.8 (0–9)

5.7 ± 3.1 (0–10)

P*

0.001

0.009

0.030

Grip strength - 1 (kg)

2.9 ± 1.4 (0.7–6)

3.3 ± 1.1 (1–5)

3.1 ± 1.4 (1–6)

Grip strength - 2 (kg)

3.3 ± 1.5 (0.6–7)

3.7 ± 1.0 (2.1–5.6)

3.5 ± 1.6 (1.4–7.1)

P*

0.078

0.121

0.001

P**

0.842

0.269

0.503

*within group comparisons, **between group comparisons,
DN4 a: DN4 Questionnaire, VAS b: Visual Analogue Scale, KT c: kinesiotape.
Values in bold are significant.

Table 3. Boston Carpal Tunnel Syndrome Questionnaire (BQ) and subscale scores of the groups.
Group 1 (KT c)
Mean ± sd (min–max)
(n = 20)

Group 2 (placebo KT)
Mean ± sd (min–max)
(n = 20)

Group 3 (orthotic device)
Mean ± sd (min–max)
(n = 20)

SSS a - 1

32 ± 8.4 (11–47)

33 ± 10.7(11–50)

31.6 ± 8.4 (13–47)

SSS - 2

20 ± 7.5 (11–35)

24.4 ± 8.0 (11–36)

28.7 ± 11.8 (14–51)

P*

<0.0001

<0.0001

0.036

FCS - 1

23.1 ± 6.0 (9–34)

19.7 ± 8.4 (8–36)

21.7 ± 7.0 (8–34)

FCS - 2

16.2 ± 5.4 (8–26)

16.3 ± 5.8 (8–27)

19.7 ± 19.7 (8–32)

P*

0.001

0.077

0.090

BQ - 1

54 ± 13.1 (20–72)

52.8 ± 17.6 (19–83)

53.4 ± 14.1 (21–77)

BQ - 2

37.7 ± 11.9 (20–56)

41.3 ± 14.7 (21–67)

48.6 ± 19.0 (23–83)

P*

<0.0001

0.011

0.038

b

P **

0.024

0.017

0.057

*within group comparisons, ** between group comparisons
SSS a: Symptom severity scale, FCS b: Functional status scale, KT c: Kinesiotape.
Values in bold are significant.

tendons. By applying KT parallel to the flexor tendons, the
pulling force of the flexors can be reduced. The reduction
in pain intensity is probably because of the reduced pulling
force to the flexor tendons that cause negative tension
from taping. The improvement in focal circulation (21)

might also be an important factor for pain relief. However,
these theories do not explain why pain relief was observed
in the placebo group. A possible explanation for this result
could be the increased attention of patients and avoiding
ergonomic mistakes and repetitive wrist movements.
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Another explanation is that the placebo KT, which was
applied improperly but in the same area, might cause pain
relief by direct mechanical stimulation to the nociceptors
or mechanoreceptors. Pain modulation through the gate
control theory is one probable rationalization for the
effectiveness of taping. It is speculated that tape stimulates
neuromuscular pathways through increased afferent
feedback (22). Increases in afferent stimulus to largediameter nerve fibers can alleviate the input received from
the small-diameter nerve fibers conducting nociception.
If the placebo KT had been applied to another area away
from the flexor retinaculum, pain relief might not have
been seen in this group. However, such an application to
the placebo KT group would avoid the blind component of
the study. This result of the study raises the question: does
the KT application technique matter at all? In order to
answer this question, a tape with different characteristics
(e.g., patches) should be applied to the same area in
another group. Further studies should be designed in order
to find the efficiency difference of several KT application
techniques for the same disease.
In a meta-analysis by Williams et al. (18), KT had at
least a small beneficial effect on strength. Hsu et al. (23)
found significantly larger increases in strength in the lower
trapezius muscle using a hand-held dynamometer, before
and after taping application, compared to a placebo. Lee et
al. (24) also found significantly higher hand grip strength
in the KT application group compared with a no-taping
condition group. Vithoulka et al. (25) investigated the
effects of KT on quadriceps peak torque during eccentric
assessment at the time of taping. Fu et al. (26) investigated
the effect of KT on quadriceps muscle strength for the
concentric contraction of the quadriceps at 180 °/s 12 h
after taping, with the tape still in situ. Contrary to the results
of those studies, Chang et al. (27) reported no significant
difference in maximal grip strength measured under three
conditions (without taping, with placebo taping, and
KT) in 21 healthy collegiate athletes. Studies that found
improvement in muscle strength by KT application differ
from the present study. In those studies, KT was applied
using the muscle facilitation technique in healthy subjects.
Secondly, some of the studies measured the strength while
the muscle was still taped.
KT is hypothesized to facilitate small immediate
increases in muscle strength by producing a concentric
pull on the fascia, which may stimulate increased muscle
contraction (28). In this study, increased grip strength was
found only in the OD group. However, the goal of taping
the KT group was to inhibit wrist flexor muscles and
correct carpal tunnel space in the present study. The aim
of this taping technique is to inhibit the muscle activity,

1048

enlarge the carpal tunnel, and reduce the pressure of
this space to decrease compression on the median nerve,
besides decreasing the pain level. On the other hand, the
patients did only gliding exercises and not strengthening
exercises in the present study. The increase in grip strength
in the OD group was not thought to be meaningful
since there was a slight increase (12%), and there was
no difference regarding grip strength among the groups.
Further studies should be designed to evaluate the effect
of KT on grip strength in patients with CTS by using a
different KT technique.
In the present study, the functional status improved
only in the KT group. Kinesiotape is a thin, porous cotton
fabric with a medical grade acrylic adhesive. The tape can
be stretched up to 140% of the original length. After taping,
the mobility of the applied muscle or joint can still be
maintained at full range. Thus, patients continue to perform
their daily tasks; however, in the OD group there is a rigid
restriction, so patients would not be able to continue daily
work activities. To understand the functional capacity in
the OD group, it would be better to evaluate these patients
later after the treatments. A similar improvement was not
observed in the placebo group. Therefore, the effect of KT
should not only be due to the nonrestrictive structure of
KT, but is probably also due to its space correction and
neural technique effects. Other subscales, SSS scores and
total BQ scores, improved in all three groups; however,
posttreatment changes were significantly different among
the groups for the SSS subscale and FSS subscale, in favor
of the KT group.
In the present study, patients were evaluated soon after
the 4-week treatment period. However, the patients were
not followed up to evaluate how long the efficacy of the
KT persists.
Another limitation of the study is the lack of exact
equality of mildly and moderately affected patients among
the groups as determined by EMG findings. The effect of
applications may differ according to the severity of EMG
findings. In order to investigate this matter, moderate and
mild CTS patients should be compared in each group.
However, larger sample sizes are needed for such analysis.
There is no evidence on the efficacy of KT treatment
for CTS. This is the first study to investigate the effects of
KT in CTS patients. Further clinical studies are needed
to determine the long-term therapeutic benefits of KT on
CTS patients.
In conclusion, KT application for the treatment of CTS
is as useful as applying an OD regarding pain relief and
superior to OD in functional status improvement. The KT
should be used as an alternative treatment method for CTS
without the disadvantage of restricting daily activities.
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